Skip to main content

March 2016, Vol 9, Seventh Annual Payers' Guide

FDA Approvals, Payers' Guide
Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals, Payers' Guide
Competition Heats Up in Rheumatoid Arthritis and Other Autoimmune Conditions
Gary Branning, MBA
Read More
FDA Approvals, Payers' Guide
Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma
Lisa A. Raedler, PhD, RPh
Read More
Page 5 of 5
Results 41 - 43 of 43